Design, synthesis and in vivo anti-inflammatory activities of 2,4-diaryl-5-4H-imidazolone derivatives. 2012

Moustafa El-Araby, and Abdelsattar Omar, and Hassanein H Hassanein, and Abdel-Ghany H El-Helby, and Asharf A Abdel-Rahman
Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Helwan University, Cairo 11790, Egypt.

A series of 2,4-diaryl-5(4H)-imidazolones were prepared and evaluated for their anti-inflammatory activities. Some selected 2,4-diaryl-5(4H)-imidazolones exhibited excellent anti-inflammatory activity in the carrageenan-induced rat paw edema model. Structure Activity Relationships within the series were studied. The substitution at the N-sulfonamide moiety by a small hydrophilic acetyl group resulted in compounds with superior in vivo anti-inflammatory properties. As expected from their COX-2 selectivity, most of the active compounds lacked gastrointestinal toxicity in vivo in rats after a 3-day treatment of 25 mg/kg/day.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008297 Male Males
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Moustafa El-Araby, and Abdelsattar Omar, and Hassanein H Hassanein, and Abdel-Ghany H El-Helby, and Asharf A Abdel-Rahman
June 2017, Bioorganic chemistry,
Moustafa El-Araby, and Abdelsattar Omar, and Hassanein H Hassanein, and Abdel-Ghany H El-Helby, and Asharf A Abdel-Rahman
April 2018, Archiv der Pharmazie,
Moustafa El-Araby, and Abdelsattar Omar, and Hassanein H Hassanein, and Abdel-Ghany H El-Helby, and Asharf A Abdel-Rahman
January 2014, Medicinal chemistry (Shariqah (United Arab Emirates)),
Moustafa El-Araby, and Abdelsattar Omar, and Hassanein H Hassanein, and Abdel-Ghany H El-Helby, and Asharf A Abdel-Rahman
January 2023, Molecules (Basel, Switzerland),
Moustafa El-Araby, and Abdelsattar Omar, and Hassanein H Hassanein, and Abdel-Ghany H El-Helby, and Asharf A Abdel-Rahman
January 2001, Bollettino chimico farmaceutico,
Moustafa El-Araby, and Abdelsattar Omar, and Hassanein H Hassanein, and Abdel-Ghany H El-Helby, and Asharf A Abdel-Rahman
December 2022, Journal of enzyme inhibition and medicinal chemistry,
Moustafa El-Araby, and Abdelsattar Omar, and Hassanein H Hassanein, and Abdel-Ghany H El-Helby, and Asharf A Abdel-Rahman
January 2012, Chemical & pharmaceutical bulletin,
Moustafa El-Araby, and Abdelsattar Omar, and Hassanein H Hassanein, and Abdel-Ghany H El-Helby, and Asharf A Abdel-Rahman
April 2022, Chinese journal of natural medicines,
Moustafa El-Araby, and Abdelsattar Omar, and Hassanein H Hassanein, and Abdel-Ghany H El-Helby, and Asharf A Abdel-Rahman
January 2014, BioMed research international,
Moustafa El-Araby, and Abdelsattar Omar, and Hassanein H Hassanein, and Abdel-Ghany H El-Helby, and Asharf A Abdel-Rahman
May 2020, Bioorganic chemistry,
Copied contents to your clipboard!